Docoh
Loading...

ENZN Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc is a pharmaceutical company engaged in developing therapeutics to patients whose needs are unmet. Its headquarters is now in Piscataway, New Jersey. The company is a publicly traded company on NASDAQ under the symbol "ENZN". It's also doing marketing works in Asia areas such as China. In 2012, the company orally presented in Nanjing, China about the symposium of its drug delivery systems, which help improve therapeutic molecules' pharmaceutical properties.

Company profile

Ticker
ENZN
Exchange
Website
CEO
Andrew Rackear
Employees
Incorporated
Location
Fiscal year end
Former names
ENZON INC, ENZON PHARMACEUTICAL INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC
SEC CIK
IRS number
222372868

ENZN stock data

(
)

Calendar

4 May 21
4 Aug 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 48.19M 48.19M 48.19M 48.19M 48.19M 48.19M
Cash burn (monthly) (positive/no burn) (positive/no burn) (positive/no burn) 87.67K (positive/no burn) 2.75K
Cash used (since last report) n/a n/a n/a 362.7K n/a 11.38K
Cash remaining n/a n/a n/a 47.82M n/a 48.18M
Runway (months of cash) n/a n/a n/a 545.5 n/a 17518.4

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
18 Nov 20 Read Randolph C Common Stock Buy Aquire P No No 0.1575 50,000 7.88K 100,450
16 Nov 20 Read Randolph C Common Stock Buy Aquire P No No 0.1511 50,450 7.62K 50,450
13 Nov 20 Jordan Bleznick Common Stock Buy Aquire P No No 0.1538 100,000 15.38K 100,000
9 Oct 20 Icahn Carl C Et Al Preferred Stock Aquire X Yes No 0 39,277 0 39,277
9 Oct 20 Icahn Carl C Et Al Common Stock Aquire X Yes No 0 29,457,750 0 36,056,636
9 Oct 20 Icahn Carl C Et Al Subscription Rights Units consisting of Common and Preferred Stock Dispose X Yes No 1090 39,277 42.81M 0
25 Aug 20 Couchman Jonathan Common Stock, $0.01 par value Sell Dispose S Yes No 0.1913 25,000 4.78K 1,590,194
24 Aug 20 Couchman Jonathan Common Stock, $0.01 par value Sell Dispose S Yes No 0.1834 52,100 9.56K 1,615,194
5 Aug 20 Couchman Jonathan Common Stock, $0.01 par value Buy Aquire P Yes No 0.2 506,292 101.26K 2,100,524

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

48.6% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 1 1
Opened positions 0 1 EXIT
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 6.09M 6.09M
Total shares 36.06M 36.06M
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Icahn Carl C Et Al 36.06M $6.09M 0.0%
Largest transactions
Shares Bought/sold Change
Icahn Carl C Et Al 36.06M 0 0.0%
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: accretion, Andrew, ASC, attempting, Authorization, beginning, behalf, Biologic, BLA, CEO, Certificate, CFO, conflict, cumulative, decision, discourage, EMA, equity, evidence, federal, Feinstein, fluctuating, Food, foregoing, found, fulfillment, greater, individual, lack, mezzanine, MMA, officially, option, optionally, overpayment, owed, PDUFA, Prescription, Priority, procedure, Rackear, rata, ratification, redemption, reduction, release, repaid, repayment, repurchase, retire, Richard, role, Separately, strike, succeed, takeover, target, unlimited, User, valid
Removed: agreed, alternative, asserted, charged, Corporation, decrease, direction, discussed, dissolution, dissolved, distribute, entered, exceeding, indefinite, intended, intention, interferon, limit, liquidated, marketed, minimal, MTC, multiple, Oncaspar, oral, periodic, postponed, reclassify, recoup, reflect, refund, regular, remaining, requisite, SC, sharply, vaccine, waive